Modification and Implementation of NCCN Guidelines™ on Non–Small Cell Lung Cancer in the Middle East and North Africa Region

Restricted access

A lung cancer committee from the Middle East and North Africa (MENA) region was established to modify the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Non–Small Cell Lung Cancer to create a platform for standard care in the region. The committee comprised different experts in thoracic oncology from the region, including the disciplines of medical and clinical oncology, radiation oncology, thoracic surgery, pulmonary medicine, radiology, and pathology. The committee reviewed version 2 of the 2009 NCCN Guidelines on Non–Small Cell Lung Cancer and identified recommendations requiring modification for the region using published evidence and relevant experience. These suggested modifications were discussed among the group and with a United States–based NCCN expert for approval. The recommended modifications, with justification and references, were categorized based on the NCCN Guidelines flow. This article describes these recommended modifications. The process of adapting the first NCCN-based guidelines in the region is a step toward helping to improve lung cancer care in the region and encouraging networking and collaboration.

Correspondence: Abdul Rahman Jazieh, MD, MPH, Department of Oncology (Mail Code 1777), P.O. Box 22490, Riyadh 11426, Kingdom of Saudi Arabia. E-mail: jazieha@ngha.med.sa
  • 1.

    ParkinDMBrayFFerlayJPisaniP. Global cancer statistics, 2002. CA Cancer J Clin2005;55:74108.

  • 2.

    AlbergAJSametJM. Epidemiology of lung cancer. Chest2003:123;21S49S.

  • 3.

    ProctorRN. Tobacco and the global lung cancer epidemic. Nat Rev Cancer2001;1:8286.

  • 4.

    CooleyMEKaiserLRAbrahmJLGiarelliE. The silent epidemic: tobacco and the evolution of lung cancer and its treatment. Cancer Invest2001:19:739751.

    • Search Google Scholar
    • Export Citation
  • 5.

    International Agency for Research on Cancer. The GLOBOCAN 2002 Database. Available at: http://www-dep.iarc.fr/globocan/database.htm. Accessed March 31 2010.

    • Search Google Scholar
    • Export Citation
  • 6.

    SalimEIMooreMAAl-LawatiJA. Cancer epidemiology and control in the Arab world—past, present and future. Asian Pac J Cancer Prev2009;10:316.

    • Search Google Scholar
    • Export Citation
  • 7.

    National Cancer Registry Saudi Arabia. Available at: http://bportal.kfshrc.edu.sa. Accessed March 31 2010.

  • 8.

    National Cancer Institute: Egypt. Cairo Registry2006. Available at: www.nci.edu.eg.

  • 9.

    JaziehAR. The principles of oncology care: back to basics. Am J Clin Oncol2009;32:330331.

  • 10.

    SumathipalaASiribaddanaSPatelV. Under-representation of developing countries in the research literature: ethical issues arising from a survey of five leading medical journals. BMC Med Ethics2004;5:E5.

    • Search Google Scholar
    • Export Citation
  • 11.

    EttingerDSAkerleyWBeplerG. NCCN clinical practice guidelines in oncology: non-small cell lung cancer. Version 22009. The most recent version is available at:www.NCCN.org. Accessed September 20 2008.

    • Search Google Scholar
    • Export Citation
  • 12.

    Rami-PortaRCrowleyJJGoldstrawP. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg2009;15:49.

  • 13.

    HerthFBeckerHDErnstA. Conventional vs endobronchial ultrasound-guided transbronchial needle aspiration: a randomized trial. Chest2004;125:322325.

    • Search Google Scholar
    • Export Citation
  • 14.

    HerthFJEberhardtRVilmannP. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax2006;61:795798.

    • Search Google Scholar
    • Export Citation
  • 15.

    HerthFJErnstAEberhardtR. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum. Eur Respir J2006;28:910914.

    • Search Google Scholar
    • Export Citation
  • 16.

    HerthFJRabeKFGaspariniS. Transbronchial and transoesophageal (ultrasound-guided) needle aspirations for the analysis of mediastinal lesions. Eur Respir J2006;28:12641275.

    • Search Google Scholar
    • Export Citation
  • 17.

    El-BayoumiESilvestriGA. Bronchoscopy for the diagnosis and staging of lung cancer. Semin Respir Crit Care Med2008;29:261270.

  • 18.

    AlbertsWM; American College of Chest Physicians. Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd edition). Chest2007;132:1S19S.

    • Search Google Scholar
    • Export Citation
  • 19.

    StraussGMHerndonJEIIMaddausMA. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol2008;26:50435051.

    • Search Google Scholar
    • Export Citation
  • 20.

    DautzenbergBArriagadaRChammardAB. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Group d'Etude et de Traitement des Cancers Bronchiques. Cancer1999;86:195196.

    • Search Google Scholar
    • Export Citation
  • 21.

    RuschVWGirouxDJKrautMJ. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of the Southwest Oncology Group trial 9416 (Intergroup trial 0160). J Thorac Cardiovasc Surg2001;121:472483.

    • Search Google Scholar
    • Export Citation
  • 22.

    ShepherdFARodrigues PereiraJ. Erlotinib in previously treated non-small cell cancer. N Engl J Med2005;353:123132.

  • 23.

    SocinskiMASchellMJPetermanA. Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell-lung cancer. J Clin Oncol2002;20:13351343.

    • Search Google Scholar
    • Export Citation
  • 24.

    CiuleanuTBrodowiczTBelaniC. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care: a randomised, double-blind, phase III study. Lancet2009:374:14321440.

    • Search Google Scholar
    • Export Citation
  • 25.

    FidiasPMDakhilSRLyssAP. Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer. J Clin Oncol2009;27;591598.

    • Search Google Scholar
    • Export Citation
  • 26.

    MaruyamaRNishiwakiYTamuraT. Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer. J Clin Oncol2008;26:42444252.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 167 139 11
PDF Downloads 30 26 3
EPUB Downloads 0 0 0